Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update Medical Device Investing
Helus Pharma Strengthens Executive Team with Appointment of Jill Conwell as Chief People Officer Medical Device Investing
Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse Technology Medical Device Investing
Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. 4Q 2025 Life Science Investing
Medtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care Medical Device Investing
Vicarious Surgical Reports Fourth Quarter and Full Year 2025 Financial Results Medical Device Investing
Pulse Biosciences Announces Clinical Data From nPulse Vybrance System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation Medical Device Investing
Boston Scientific to host investor event at the 75th Annual Scientific Session of the American College of Cardiology Life Science Investing
